home · filing · 0001213900-23-004105
8-K filed January 20, 2023, 6:59 PM ET
ticker ALLR
CIK 0001860657
leadership
confidence high
sentiment neutral
materiality 0.70
Allarity Therapeutics: three directors resign, board size reduced to 5; annual meeting adjourned to Feb 3
Allarity Therapeutics, Inc.
Directors Duncan Moore and Gail Maderis resigned Jan 19, 2023; Soren G. Jensen resigns effective Feb 4, 2023.
Board reduced fixed number of authorized directors from 7 to 5 following the resignations.
2023 annual meeting adjourned on Jan 19 without business; reconvenes Feb 3, 2023 for additional voting time.
Resignations stated as for personal reasons, not due to disagreements with company operations or policies.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2023-01-19
Filed January 20, 2023, 6:59 PM ET
On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.
Effective 2023-01-19
Filed January 20, 2023, 6:59 PM ET
On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.
Effective 2023-02-04
Filed January 20, 2023, 6:59 PM ET
On January 19, 2023, Mr. Soren G. Jensen gave notice that he will resign as a director, to be effective as of February 4, 2023.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gail Maderis resigned as Director at Allarity Therapeutics, Inc..
Action resigned
Role Director
Exact text from the filing
On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Duncan Moore resigned as Director at Allarity Therapeutics, Inc..
Action resigned
Role Director
Exact text from the filing
On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Soren G. Jensen resigned as Director at Allarity Therapeutics, Inc..
Action resigned
Role Director
Exact text from the filing
On January 19, 2023, Mr. Soren G. Jensen gave notice that he will resign as a director, to be effective as of February 4, 2023.
View on SEC.gov
Source: SEC EDGAR
accession 0001213900-23-004105
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.